WHO Concludes Agreement Relating to Pandemic

(3 Minutes Read)

During COVID-19, it was largely American research and development that produced the most effective vaccines and medicines. Weeks after Trump’s decision, Argentina’s President Javier Milei also exited the WHO, citing “profound differences” with the U.N. agency.

Negotiations concluded early Wednesday on an agreement relating to the pandemic is expected to be adopted next month at the WHO’s annual meeting in Geneva.

WHO Director-General Tedros Adhanom Ghebreyesus heralded it as a historic moment, saying countries have proven that “in our divided world, nations can still work together to find common ground and a shared response.”

Following U.S. President Donald Trump’s decision to withdraw the country from the WHO in January, American officials were barred from participating in the talks and are not expected to sign the treaty.

During COVID-19, it was largely American research and development that produced the most effective vaccines and medicines. Weeks after Trump’s decision, Argentina’s President Javier Milei also exited the WHO, citing “profound differences” with the U.N. agency.

Read Also:

https://trendsnafrica.com/who-head-appeals-to-member-states-to-dissuade-trump-from-exit/

Rachael Crockett, of the advocacy group Drugs for Neglected Diseases Initiative, described the draft pandemic treaty as “a product of compromise.” She said it contained strong provisions, but only if countries chose to implement them.